Briefcase

Racial/Ethnic Disparities in Gastroenterology Care: Real-World Strategies to Address Inequities in Treatment and Outcomes

Launch Date
01/23/2024
Credit Amount
0.75
Credit Expires
01/23/2027

Faculty

Monica E. Peek, MD, MPH, MSc
(she/her/hers)
Ellen H. Block Professor of Health Justice in the Department of Medicine
Associate Director, Chicago Center for Diabetes Translation Research
Director of Research, MacLean Center for Clinical Medical Ethics
The University of Chicago
Chicago, IL
Monica E. Peek, MD, MPH, MSc

Monica Peek, MD, MPH, MSc is an Ellen H. Block Professor of Health Justice in the Department of Medicine. She is also the Associate Director, Chicago Center for Diabetes Translation Research, and Director of Research, MacLean Center for Clinical Medical Ethics. She is a practicing internist, medical educator, and clinician investigator. Her research pursues health equity and social justice, with a focus on promoting equitable doctor/patient relationships among racial minorities, integrating the medical and social needs of patients, and addressing health care discrimination and structural racism impacting health outcomes (e.g., diabetes, COVID-19). Dr. Peek has authored more than 200 peer-reviewed publications and abstracts on health care disparities, diversity, and bias; has been the principal investigator of multiple grants to address health disparities; and has been invited to speak at numerous local and national medical meetings.

Anita Afzali, MD, MPH, MHCM, FACG, AGAF
Professor of Clinical Medicine
Division of Digestive Diseases
Executive Vice Chair of Medicine
Department of Internal Medicine
University of Cincinnati College of Medicine
Associate Chief Medical Officer
UC Health System
Cincinnati, OH
Anita Afzali, MD, MPH, MHCM, FACG, AGAF

Anita Afzali, MD, MPH, MHCM, is a Professor of Clinical Medicine and a gastroenterologist that specializes in Inflammatory Bowel Disease (IBD). She has recently transitioned to the University of Cincinnati after successfully building the first standalone multidisciplinary IBD Center and serving as the Medical Director at The Ohio State University Wexner Medical Center for five years. Dr. Afzali is now the Executive Vice Chair of the Department of Internal Medicine at the University of Cincinnati and Associate Chief Medical Officer of UC Health Systems and Cincinnati Children’s Hospital. She received her medical degree and completed both an Internal Medicine residency and Gastroenterology fellowship at the University of Washington in Seattle, WA. While in fellowship, Dr. Afzali worked in outcomes research and epidemiology and graduated with a Master’s in Public Health. She recently obtained an additional Master’s in Health Care Management for physician executive leadership and business administration from Harvard University. Her areas of research interest include clinical outcomes and clinical trials for investigative therapies and diagnostics in IBD. She is a healthcare redesign leader with interests in clinical operations and transformative medical care delivery. Dr. Afzali has extensive peer-reviewed publications and is a clinical trialist in over 20 investigative drug and diagnostic trials. She is also an invited lecturer on national and international programs and serves on several international advisory boards and scientific committees. Dr. Afzali is the incoming Chair of the American College of Gastroenterology (ACG) Educational Affairs Committee and the incoming Chair of the World Gastroenterology Organization (WGO) Publications Committee, as well as Co-Editor of the WGO quarterly global newsletters.

Explore By Section
Statement of Need Learning Objectives Financial Support Target Audience Credit Information Disclosure Declaration Obtaining Credit

Statement of Need

Despite the rising prevalence of inflammatory bowel disease (IBD) among racial and ethnic underserved populations, disparities in diagnosis, treatment, and outcomes remain. Patients of color are more likely to present with more severe disease, sometimes with extraintestinal manifestations. However, even after controlling for disease severity for both ulcerative colitis and Crohn’s disease, Black and Hispanic patients are not only less likely to receive appropriate biologic therapy, but also have higher rates of cumulative surgeries than their White and Asian counterparts. It is imperative that each member of the multidisciplinary care team works together to address these disparities in order to improve equity in treatment and outcomes for all patients.

In this CMEO BriefCase, expert faculty will utilize case-based learning to illustrate these pervasive disparities through the stories of two patients, Harold and April, while offering strategies to address inequities in the treatment and outcomes of patients with IBD.

Learning Objectives

At the conclusion of this activity, learners will be able to better:

  • Implement strategies to address inequities in the treatment and outcomes of patients with ulcerative colitis
  • Implement strategies to address inequities in the treatment and outcomes of patients with Crohn’s disease

Financial Support

Supported by an educational grant provided by Johnson & Johnson.

Target Audience

Physicians specializing in gastroenterology, surgery, or primary care, physician associates (PAs), nurse practitioners (NPs), nurses, pharmacists, and dieticians

Credit Information

Jointly Accredited Provider

In support of improving patient care, CME Outfitters, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Interprofessional (IPCE) 0.75

This activity was planned by and for the healthcare team, and learners will receive 0.75 Interprofessional Continuing Education Credit for learning and change.

Physicians (ACCME) 0.75

CME Outfitters, LLC, designates this Enduring Material for a maximum of 0.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurses (ANCC) 0.75

This activity is designated for 0.75 contact hours.

California Residents: This continuing nursing education activity was approved by the California Board of Registered Nursing. CME Outfitters LLC’s provider number is CEP15510.

Pharmacists (ACPE) 0.75

This application-based activity is approved for 0.75 contact hours ( 0.075 CEUs) of continuing pharmacy credit ( JA0007185-0000-24-009-H01-P ).

PAs (AAPA) 0.75

CME Outfitters, LLC, has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 0.75 AAPA Category 1 CME credits. Approval is valid until 01/23/2027. PAs should only claim credit commensurate with the extent of their participation.

ABIM MOC 0.75

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.75 medical knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

MIPS Improvement Activity

Completion of this accredited CME activity meets the expectations of an Accredited Safety or Quality Improvement Program (IA_PSPA_28) for the Merit-based Incentive Payment Program (MIPS). Clinicians should submit their improvement activities by attestation via the CMS Quality Payment Program website.

Royal College MOC

Through an agreement between the Accreditation Council for Continuing Medical Education and the Royal College of Physicians and Surgeons of Canada, medical practitioners participating in the Royal College MOC Program may record completion of accredited activities registered under the ACCME’s “CME in Support of MOC” program in Section 3 of the Royal College’s MOC Program.

Disclosure Declaration

Dr. Peek reports no financial relationships to disclose.

Dr. Afzali reports the following financial relationships:

Advisory Board and Consultant: AbbVie Inc.; Bristol Myers Squibb Company; Janssen Pharmaceuticals, Inc.; Lilly; Pfizer Inc.; and Takeda Pharmaceuticals U.S.A., Inc.

Speakers Bureau: AbbVie Inc. Bristol Myers Squibb Company; Janssen Pharmaceuticals, Inc.; Pfizer Inc.; and Takeda Pharmaceuticals U.S.A., Inc.

Other Financial or Material Support: IBDHorizons – Founder, Board Member and Scrubs & Heels – Founder, Board Member

The following individuals have no financial relationships to disclose: 

Marlon “Tony” Graham, MD (Peer Reviewer)
Albert Eubanks, Jr., RN (Peer Reviewer)
Morgan Stockberger, MD (Planning Committee)
Jessica Whelan, DNP, APRN, FPMHNP-BC, RN-BC (Planning Committee)
Susan H. Yarbrough, CHCP (Planning Committee)
Sandra Caballero, PharmD (Planning Committee)
Sharon Tordoff (Planning Committee)

Obtaining Credit

Post-tests, credit request forms, and activity evaluations must be completed online (requires free account activation), and participants can print their certificate or statement of credit immediately (0% pass rate required). This website supports all browsers except Internet Explorer for Mac.

Questions about this activity?

Call us at 877.CME.PROS (877.263.7767).

BC-111-012324-57

Racial/Ethnic Disparities in Gastroenterology Care: Real-World Strategies to Address Inequities in Treatment and Outcomes
Event Date: 01/23/2024
Begin